GMED
Globus Medical Inc Class A · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website globusmedical.com
- Employees(FY) 2600
- ISIN US3795772082
Performance
-0.1%
1W
-0.83%
1M
+17.04%
3M
+23.29%
6M
+55.06%
YTD
+59.3%
1Y
Profile
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales presence, as well as its hip and knee products primarily through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Technical Analysis of GMED 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-19 12:55
- 2024-12-19 08:15
- 2024-12-19 08:15
- 2024-12-19 07:30
- 2024-12-18 09:47
- 2024-12-18 07:54
- 2024-12-17 19:00
GMED: Raising target price to $88.00(Argus Research)
- 2024-12-17 11:48
- 2024-12-17 09:45
- 2024-12-13 10:20
- 2024-12-13 06:48
- 2024-12-12 12:21
- 2024-12-12 11:51
- 2024-12-12 06:43
- 2024-12-12 02:15
- 2024-12-11 14:59
Inari Medical Stock Gets RS Rating Upgrade(Investor's Business Daily)
- 2024-12-11 12:17
- 2024-12-11 07:53
- 2024-12-10 19:00
GMED: Lowering target price to $87.00(Argus Research)
- 2024-12-10 11:14
- 2024-12-09 12:17
- 2024-12-06 08:54
- 2024-12-06 08:50
- 2024-12-06 08:46
- 2024-12-05 12:00
- 2024-12-05 11:44
- 2024-12-05 11:30
- 2024-12-05 11:07
- 2024-12-04 12:30
- 2024-12-04 07:47
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.